Atlas Trials

Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients

Clinical trial NCT06146478 · COMPLETED

Trial details

NCT number
NCT06146478
Sponsor
Blood Care Clinic
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Transfusion-dependent Beta-Thalassemia
Start date
2022-01-25
Primary completion
2023-07-20
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.